Finasteride for Hair Loss: Does It Work? A Pharmacist's Guide

Male pattern hair loss affects around 50% of men by age 50. Finasteride is the only oral medication licensed in the UK with strong clinical evidence to slow, stop, and in many cases reverse it. The question most patients ask is not whether finasteride works, the data is clear that it does, but whether it's right for them, how long it takes, and whether the side effects are worth it.

What causes male pattern hair loss?

Caused by dihydrotestosterone (DHT), a potent androgen derived from testosterone via the enzyme 5-alpha reductase type II. In genetically predisposed men, DHT causes progressive miniaturisation of scalp hair follicles, producing progressively shorter, finer hairs over successive growth cycles until they stop producing visible hair. The pattern follows the characteristic M-shaped recession at the temples and thinning at the crown. Follicles at the back and sides of the scalp are not DHT-sensitive, which is why they remain unaffected.

How does finasteride work?

Finasteride 1mg is a type II 5-alpha reductase inhibitor. It blocks the conversion of testosterone to DHT, reducing serum DHT by approximately 70% and scalp DHT by approximately 64% at the standard 1mg daily dose. By reducing DHT it removes the primary hormonal driver of follicle miniaturisation. The mechanism is protective and restorative, allowing miniaturised follicles to recover their normal growth cycle, not stimulating new follicles from scratch.

What does the clinical evidence show?

The pivotal trials enrolled 1,553 men aged 18 to 41 with male pattern hair loss across two 1-year studies, with 1,215 continuing to a second year (Kaufman KD et al, JAAD 1998. Finasteride Male Pattern Hair Loss Study Group).

Key findings at 2 years:

• 83% of men on finasteride had no further hair loss (vs 28% on placebo)
• 66% showed photographic improvement in hair growth (vs 7% placebo)
• Hair count in the vertex increased by an average of 138 hairs in a 5.1cm² area vs baseline
• Placebo group showed progressive hair loss throughout

A systematic review and meta-analysis (Gupta AK et al, Dermatol Ther 2021) confirmed finasteride 1mg significantly increased total hair count vs placebo at 24 weeks (mean difference +12.4 hairs/cm²) and 48 weeks (mean difference +16.4 hairs/cm²). Five-year extension data showed benefits maintained with continued treatment; patients who stopped typically experienced a gradual return of hair loss within 12 months as DHT levels normalised.

How long does finasteride take to work?

The most important expectation to set correctly.

Months 1 to 3: No visible improvement. Shedding may temporarily increase as the hair cycle resets. This is normal, not a sign of failure. DHT is being suppressed from the first dose, but follicle recovery takes time.

Months 3 to 6: Shedding typically stabilises. Hair loss slows noticeably. Early signs of thickening may appear at the crown.

Months 6 to 12: Most patients see visible improvement. Significant results at 12 months in clinical trials.

12 to 24 months: Continued improvement. Year-2 data showed better results than year-1, confirming the response is cumulative.

Key principle: finasteride requires at least 12 months of consistent daily use before a meaningful assessment of efficacy. Stopping at 3 months because "nothing has happened" is the most common, and most preventable, reason for treatment failure.

Does finasteride work for frontal hair loss?

The clinical evidence is strongest for vertex (crown) hair loss. The frontal hairline is less responsive, trials showed less consistent benefit in the frontal and parietal scalp compared to the vertex. Many patients see some frontal improvement, but results are more modest and less predictable. For patients whose primary concern is a receding hairline, combining finasteride with topical minoxidil often produces better outcomes than either medication alone.

Combining finasteride with minoxidil

Finasteride and minoxidil work through entirely different mechanisms and are highly complementary. Finasteride addresses the hormonal cause; minoxidil (a topical vasodilator) increases blood flow to follicles and extends the anagen growth phase. Multiple studies support the combination producing superior results to either alone. Both are available at Solira and can be prescribed alongside each other following consultation.

Side effects, the honest picture

Sexual side effects

Phase III clinical trial data over 1 year (Kaufman KD et al, JAAD 1998):

• Decreased libido: 1.8% finasteride vs 1.3% placebo
• Erectile dysfunction: 1.3% vs 0.7% placebo
• Decreased ejaculatory volume: 1.2% vs 0.6% placebo

These rates affect approximately 1 in 50 to 1 in 100 patients. In the clinical trials, the majority of these side effects resolved either during continued treatment or after stopping.

Post-finasteride syndrome

A subset of patients report persistent sexual, neurological, and psychological symptoms continuing after stopping finasteride. Its existence as a clinical entity is accepted; prevalence and mechanisms remain areas of ongoing research. The FDA added a warning about depression to the finasteride label in 2011. Patients with a personal or family history of depression or mood disorders should discuss this with their prescribing pharmacist before starting.

Other side effects

Gynaecomastia (breast tenderness or enlargement) is rare but recognised. Finasteride is a teratogen, pregnant women or those who may become pregnant must not handle crushed or broken tablets, due to risk of harm to male foetal development. Finasteride reduces PSA levels by approximately 50%, men being monitored for prostate cancer risk must inform their doctor, as PSA results require interpretation with this in mind.

Who is finasteride suitable for?

Men aged 18 and over with androgenetic alopecia. Strongest evidence for vertex and crown thinning. Requires daily dosing and a committed 12-month assessment period. Not licensed for women. Contraindicated in women who are pregnant or may become pregnant.

What happens if you stop?

Hair loss typically resumes within 6 to 12 months of stopping treatment as DHT levels return to normal. The gains made during treatment are not permanent without continued DHT suppression. For most patients who respond well, finasteride is a long-term commitment.

Reviewed by Jimah Alsaai MPharm, GPhC 2232652, Superintendent Pharmacist, Solira.